Perinatal outcomes in HIV-positive women
In 2015, the majority (80%) of the 1.2 million HIV-positive pregnant women globally, most of whom reside in sub-Saharan Africa (91%), received antiretroviral treatment (ART) for the prevention-of- mother-to-child-transmission (PMTCT). The use of Highly Active Antiretroviral Treatment (HAART) during...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757727 |